Computerized System Validation
Risk-based CSV strategy, URS, validation planning, IQ/OQ/PQ, requirements traceability, audit-trail review and validation closure aligned with GAMP 5, EU GMP Annex 11 and FDA 21 CFR Part 11.
About PHARPRO
PHARPRO is a founder-led consultancy helping regulated pharmaceutical and life-sciences organisations turn requirements into practical documentation, qualified systems, defensible evidence and capable internal teams.
Company profile
PHARPRO Consultation Company L.L.C FZ was established in the UAE in 2023. Technical delivery is led by founder Mohammad Awawdeh from Amman, Jordan. PHARPRO engagements have reached Jordan, the UAE, Switzerland, Iraq, Egypt, Pakistan and Syria. Mohammad’s earlier Saudi Arabia site-establishment work was completed during his employment with MS Pharma and is presented separately from PHARPRO’s company record.
Risk-based CSV strategy, URS, validation planning, IQ/OQ/PQ, requirements traceability, audit-trail review and validation closure aligned with GAMP 5, EU GMP Annex 11 and FDA 21 CFR Part 11.
GMP gap assessments, data-integrity reviews, CAPA, SOP systems, mock audits and remediation plans designed around the applicable authority, product and operating model.
Qualification of equipment, HVAC, utilities, warehouses and cold rooms, including DQ/IQ/OQ/PQ, risk-based protocols and clear acceptance evidence.
Practical GMP and CSV training in English or Arabic, plus PHARPRO DVS for controlled, AI-assisted validation document workflows with human review and approval.
As of August 2026: 12 completed consulting and training engagements, two active projects, seven PHARPRO markets and six or more organisations trained.
Named project scopes are separated from confidential outcomes. Logos, participant photographs, quotations and performance metrics are published only with confirmation of reuse rights.
How we work
PHARPRO’s role is to identify risk, build usable controls and make the resulting evidence easy to defend. Regulatory claims are always evaluated against the client’s actual product, process, system and target market.
Agree the regulatory scope, intended use, responsibilities, acceptance criteria and final decision owner before creating documents.
Prioritise patient safety, product quality and data integrity so effort is concentrated where failure has the greatest impact.
Deliver controlled documents, traceable evidence and knowledge transfer that the client’s own quality team can maintain after project closure.

Leadership
PHARPRO was founded by Mohammad Awawdeh, a pharmaceutical compliance consultant with more than seven years of hands-on validation experience. He leads sales conversations, project scoping and technical delivery across CSV, quality assurance, CQV, GMP training and digital validation—so the person defining the work remains accountable for its execution.
Share the system, inspection priority or validation challenge. PHARPRO will recommend a practical starting point and normally respond within one business day.
Request a free assessment